These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 21156825

  • 1. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
    Yuen CY, Wong WT, Tian XY, Wong SL, Lau CW, Yu J, Tomlinson B, Yao X, Huang Y.
    Cardiovasc Res; 2011 Apr 01; 90(1):122-9. PubMed ID: 21156825
    [Abstract] [Full Text] [Related]

  • 2. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
    Knorr M, Hausding M, Kröller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A, Münzel T.
    Arterioscler Thromb Vasc Biol; 2011 Oct 01; 31(10):2223-31. PubMed ID: 21757654
    [Abstract] [Full Text] [Related]

  • 3. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
    Cheang WS, Wong WT, Tian XY, Yang Q, Lee HK, He GW, Yao X, Huang Y.
    Cardiovasc Res; 2011 Nov 01; 92(2):267-75. PubMed ID: 21875904
    [Abstract] [Full Text] [Related]

  • 4. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
    Liu CQ, Leung FP, Wong SL, Wong WT, Lau CW, Lu L, Yao X, Yao T, Huang Y.
    Biochem Pharmacol; 2009 Aug 15; 78(4):374-81. PubMed ID: 19409373
    [Abstract] [Full Text] [Related]

  • 5. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, Hirata H, Machida Y, Shinoda M, Suzuki N, Matsuoka H.
    Am J Hypertens; 2008 May 15; 21(5):576-81. PubMed ID: 18437150
    [Abstract] [Full Text] [Related]

  • 6. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I, Ichiki T, Inanaga K, Ohtsubo H, Fukuyama K, Ono H, Hashiguchi Y, Sunagawa K.
    Cardiovasc Res; 2006 Oct 01; 72(1):184-90. PubMed ID: 16938288
    [Abstract] [Full Text] [Related]

  • 7. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
    Scalera F, Martens-Lobenhoffer J, Bukowska A, Lendeckel U, Täger M, Bode-Böger SM.
    Hypertension; 2008 Mar 01; 51(3):696-703. PubMed ID: 18250362
    [Abstract] [Full Text] [Related]

  • 8. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
    Li H, Lu W, Cai WW, Wang PJ, Zhang N, Yu CP, Wang DL, Liu BC, Sun W.
    Pulm Pharmacol Ther; 2014 Jun 01; 28(1):17-24. PubMed ID: 24269521
    [Abstract] [Full Text] [Related]

  • 9. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
    Ikejima H, Imanishi T, Tsujioka H, Kuroi A, Kobayashi K, Shiomi M, Muragaki Y, Mochizuki S, Goto M, Yoshida K, Akasaka T.
    J Hypertens; 2008 May 01; 26(5):964-72. PubMed ID: 18398339
    [Abstract] [Full Text] [Related]

  • 10. AT1 receptor blocker potentiates shear-stress induced nitric oxide production via modulation of eNOS phosphorylation of residues Thr(495) and Ser(1177.).
    Barauna VG, Mantuan PR, Magalhães FC, Campos LC, Krieger JE.
    Biochem Biophys Res Commun; 2013 Nov 29; 441(4):713-9. PubMed ID: 24211212
    [Abstract] [Full Text] [Related]

  • 11. Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity.
    Toyama K, Nakamura T, Kataoka K, Yasuda O, Fukuda M, Tokutomi Y, Dong YF, Ogawa H, Kim-Mitsuyama S.
    Biochem Biophys Res Commun; 2011 Jul 08; 410(3):508-13. PubMed ID: 21679694
    [Abstract] [Full Text] [Related]

  • 12. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
    Toba H, Wang J, Ohigashi M, Kobara M, Nakata T.
    Pharmacology; 2013 Jul 08; 92(5-6):265-75. PubMed ID: 24281041
    [Abstract] [Full Text] [Related]

  • 13. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
    Chaudagar KK, Mehta AA.
    Clin Exp Hypertens; 2014 Jul 08; 36(8):557-66. PubMed ID: 24490705
    [Abstract] [Full Text] [Related]

  • 14. Telmisartan-induced eNOS gene expression is partially independent of its PPAR-gamma agonist property.
    Ríos NB, Esparragón FR, Rodríguez Pérez JC.
    Clin Invest Med; 2012 Apr 01; 35(2):E55-64. PubMed ID: 22469105
    [Abstract] [Full Text] [Related]

  • 15. Nitric-oxide synthase knockout modulates Ca²⁺-sensing receptor expression and signaling in mouse mesenteric arteries.
    Awumey EM, Bridges LE, Williams CL, Diz DI.
    J Pharmacol Exp Ther; 2013 Jul 01; 346(1):38-47. PubMed ID: 23639802
    [Abstract] [Full Text] [Related]

  • 16. Therapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation.
    Chan YC, Leung FP, Wong WT, Tian XY, Yung LM, Lau CW, Tsang SY, Yao X, Chen ZY, Huang Y.
    Arterioscler Thromb Vasc Biol; 2010 May 01; 30(5):992-9. PubMed ID: 20185791
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro.
    Leung FP, Yung LM, Leung HS, Au CL, Yao X, Vanhoutte PM, Laher I, Huang Y.
    Br J Pharmacol; 2007 Sep 01; 152(2):223-9. PubMed ID: 17618301
    [Abstract] [Full Text] [Related]

  • 18. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries.
    Lekontseva O, Chakrabarti S, Jiang Y, Cheung CC, Davidge ST.
    J Pharmacol Exp Ther; 2011 Nov 01; 339(2):367-75. PubMed ID: 21807885
    [Abstract] [Full Text] [Related]

  • 19. Telmisartan prevents angiotensin II-induced endothelial dysfunction in rabbit aorta via activating HGF/Met system and PPARγ pathway.
    Hu ZP, Fang XL, Qian HY, Fang N, Wang BN, Wang Y.
    Fundam Clin Pharmacol; 2014 Oct 01; 28(5):501-11. PubMed ID: 24188213
    [Abstract] [Full Text] [Related]

  • 20. Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.
    Baron-Menguy C, Toutain B, Cousin M, Dumont O, Guihot AL, Vessières E, Subra JF, Custaud MA, Loufrani L, Henrion D.
    Hypertens Res; 2010 Aug 01; 33(8):857-66. PubMed ID: 20535114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.